It was a big news year for structural heart disease. For tricuspid regurgitation, two devices were approved in quick ...

New techniques and devices made headway in tough treatment scenarios, and guidelines stressed the need for collaborative care ...

Headlining the year’s developments were studies of catheter ablation and concomitant use of LAAO in patients with AF.

Researchers delved into the two “neutral” studies using Bayesian methods: a clearer picture of angiography’s role has emerged ...

The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

With new data from several studies this year, researchers are chipping away at the question of when to revascularize and how.

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

Mean CV health score, which ranges from 0 (worst) to 100 (best), was 82.6 in early childhood, 84.1 in mid-childhood, 82.0 in ...

As an end-of-year gift, one fellow offers bits of advice he’s gotten that have helped him succeed in interventional ...

One in 20 of the young adult participants had arrhythmias—some occurred many hours later when they were sobering up.

PLATO investigators dismiss the paper as nothing new, but some clinicians say that, after 15 years, it’s hard not to have ...

This small study suggests there’s much still to learn about how best to handle the complexity of repeat procedures.